Analyst Rashad Kawan of Morgan Stanley maintained a Hold rating on Fevertree Drinks (FQVTF – Research Report), with a price target of p765.00.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Rashad Kawan has given his Hold rating due to a combination of factors that reflect both opportunities and challenges for Fevertree Drinks. The company is performing in line with expectations, with projected low single-digit revenue growth and an adjusted EBITDA margin of approximately 12% for FY25. This suggests stability but not significant growth potential.
In the UK, Fevertree maintains its leading market position, while in the US, it is experiencing strong brand momentum and is progressing well with its partnership with Molson Coors. However, the 10% tariff on UK imports into the US poses a short-term challenge, although Fevertree plans to mitigate this through local production. In Europe, the company sees positive trends in markets like the Netherlands and France, but sales remain subdued in Germany. Overall, these mixed signals contribute to the Hold rating, indicating that while Fevertree is stable, it may not offer substantial upside in the near term.
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue